DOCSLIB.ORG

Study on a Deadly Uninvited Guest During the Historical Second Wave at a Tertiary Health Care Center in South India

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Study on a Deadly Uninvited Guest During the Historical Second Wave at a Tertiary Health Care Center in South India Original Research Article Study on a deadly uninvited guest during the historical second wave at a tertiary health care center in south India Sunil Kumar Katari1, Suneetha Sunkari2, Bhargavi3*, T Khadeeja4, C Aparna5, G Baleswari6 1Assistant Professor, 2Assistant Professor, 3,4PG, 5Professor, 6Professor and HOD, Department of Pathology, Kurnool Medical College, Kurnool 518002. Andhra Pradesh, INDIA. Email: [email protected] Abstract Background: Mucormycotina are widely distributed fungal elements in nature and cause no harm to immunocompetent individuals, but they infect immunosuppressed people causing mucormycosis. Mucormycosis in Severe coronavirus disease (COVID-19) during the first wave escaped unnoticed in many healthcare centers while only a few cases were reported during 2020 in India. As mucormycosis is an invasive fungal infection, accurate identification and diagnosis of Mucormycotina on histopathological examination assists the clinician in further treatment. Aim of the study: To know the incidence of Mucormycosis in the histological specimens received. To know the Age, Sex and Site wise distribution of the same. To compare the present study with other global studies regarding incidence, age and gender wise distribution and suspect: histopatholocally confirmed ratio. Material and Methods: This is a prospective study done in the department of Pathology, Kurnool Medical College, Kurnool, on 162 biopsy specimens sent from patients of Severe coronavirus disease (COVID-19) suspected with mucormycosis of the Rhino-orbito-cerebral regions who underwent surgery in Government General Hospital, Kurnool, from 25st April 2021 to 20th June 2021 (56 days). The biopsy specimens were processed and studied. Results: Within a span of 56 days, out of 162 specimens received, 116 were histopathologically confirmed positive for mucormycosis. Conclusion: Severe coronavirus disease (COVID-19) is changing its course through unexpected life-threatening manifestations of which mucormycosis is one such entity in this second wave. As per the literature mucormycotina is a frequent contaminant in culture media, so histopathological examination always stands as a gold standard. Being invasive fungus with high mortality rate, any hint of mucormycosis in patients of Severe coronavirus disease (COVID-19) should be promptly treated medically and also surgically wherever required in order to contain the morbidity and mortality by this deadly black fungus. Keywords: Mucormycosis, Covid 19, Black fungus, diabetes, Histopathology, angioinvasion, immunosuppressed. *Address for Correspondence: Dr Bhargavi, Department of Pathology, Kurnool Medical College, Kurnool 518002. Andhra Pradesh, INDIA Email: [email protected] Received Date: 22/06/2021 Revised Date: 01/07/2021 Accepted Date: 25/07/2021 DOI: https://doi.org/10.26611/1052011 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. and Cunninghamella spp., which belong to the subphylum Access this article online Mucormycotina. Mucormycotina cause no harm to immunocompetent individuals but infect Quick Response Code: Website: immunosuppressed people resulting in mucormycosis. www.medpulse.in Major predisposing factors are neutropenia, use of corticosteroids, Diabetes mellitus, iron overload and breakdown of cutaneous barrier as a result of burns, 1 Accessed Date: surgical wounds and trauma . Severe coronavirus disease (COVID-19) in itself alters the innate immunity due to 04 October 2021 COVID-19-associated immune dysregulation characterized by decreased T cells, including CD4 and 2,3 CD8 cells. Mucormycosis in Severe coronavirus disease INTRODUCTION (COVID-19) during the first wave escaped unnoticed in Mucormycosis is an opportunistic infection caused by many health care centers while only a few cases were environmental fungi including mucor spp., Rhizopus spp., reported.3 Initially while COVID-19 associated pulmonary How to cite this article: Sunil Kumar Katari et al. Study on a deadly uninvited guest during the historical second wave at a tertiary health care center in south India. MedPulse International Journal of Pathology. October 2021; 20(1): 01-05. https://www.medpulse.in/Pathology/ MedPulse International Journal of Pathology, Print ISSN: 2550-7605, Online ISSN: 2636-4697, Volume 20, Issue 1, October 2021 pp 01-05 aspergillosis was increasingly recognized, mucormycosis be sparse or fragmented6. In lesions exposed to air, thick- which was rare previously has now become the deadly walled spherical structures can form at the ends of the addition to this Covid 19 spectrum. All physicians hyphae9. Routine HandE stains may show only the cell including ophthalmologists should, therefore, be aware of wall with no structure inside. In immunosuppressed hosts, the probability of development of opportunistic fungal the hyphal elements will be found with abundant necrosis, infections such as mucormycosis in patients with COVID- hemorrhage, and blood vessel thrombosis10. Important 19 illness, especially in those with comorbidities and on diagnostic features include identification of fungal immunosuppressive agents in the coming future4. elements invading the blood vessel wall or inside their Mucormycotina are ubiquitous in the environment and can lumen6. Sparse neutrophilic inflammation can be found in be found in soil and decomposing matter5. Their spores are the periphery of the lesion. easily airborne, which can cause contamination of Pitfalls in morphological diagnosis: The major microbiological culture media6. So not all culture results morphological differentiation should be done among are reliable. As mucormycosis is an invasive fungal Mucorales genera, Aspergillus spp., and Candida spp5. infection, accurate identification and diagnosis of The presence of abundant septation and acute-angle Mucormycotina on histopathological examination assists branching should suggest the diagnosis of Aspergillus the clinician in further treatment. spp., while yeasts with pseudo-hyphae should suggest Aim of the study: To know the incidence of Candida spp. Poor staining of hyphae with GMS Mucormycosis in the histological specimens received. To (Grocott’s methenamine silver stain) should suggest know the Age, Sex and Site wise distribution of the same. mucormycosis. In order to specifically identify Mucorales To compare the present study with other global studies in tissues or to detect dual infections by Mucorales genera regarding incidence, age and gender wise distribution and and other fungi, it is important to use suspect : histopatholocally confirmed ratio. immunohistochemistry, in situ hybridization, or PCR15,16. RESULTS MATERIAL AND METHODS With the approval of the ethics committee, this prospective Total no. of histopathological specimens received during 486 study was done in the department of Pathology, Kurnool the present study Medical College, Kurnool, on 162 biopsy specimens sent Total no. of specimens suspecting Mucormycosis 162 from patients of Severe coronavirus disease (COVID-19) Total no. of specimens histopathologically positive for 116 suspected with mucormycosis of the Rhino-orbito-cerebral Mucormycetes regions who underwent surgery in Government General Out of 486 biopsy specimens received in the Hospital, Kurnool, from 25th April 2021 to 20th June 2021. histopathology department during the period of present (56 Days) study, 162 were from patients of Severe coronavirus Inclusion criteria: All resected tissues of Rhino-orbito- disease (COVID-19) treated in GGH Kurnool, who were cerebral regions of Severe coronavirus disease (COVID- suspected to have developed Mucormycosis. These 19) patients suspected of mucormycosis were included in patients underwent surgical resection of affected tissues from the paranasal sinuses and orbital regions. the present study. Exclusion criteria: All resected tissues from non-covid patients were excluded from the present study. All the specimens were fixed in 10% neutral buffered formalin, processed in Automatic tissue processor into paraffin embedded sections and stained with routine Hematoxylin and Eosin stain, examined under light microscopy and correlated with clinical and radiological findings. The histopathological reports were analyzed with respect to age, sex and site wise distribution Graph 1: Proportion of Mucormycosis suspected specimens mucormycosis. The data was properly tabulated and analyzed. Results and Conclusion were derived from such Of the 162 biopsy specimens received, 116 were analysis. The data shown in charts was prepared using histopathologically confirmed positive for mucormycosis. Microsoft Excel Software. Identifying Mucormycosis on histopathology: Mucormycetes form non-septate hyphae of variable width (6-50µm) with frequent right-angle branching1. The hyphae may vary in width, appear folded or crinkled, and MedPulse International Journal of Pathology, Print ISSN: 2550-7605, Online ISSN: 2636-4697, Volume 20, Issue 1, October 2021 Page 2 Sunil Kumar Katari et al. Graph 2: Percentage of Mucormycosis positive confirmed cases Table 1: Site wise and Sex wise Distribution of Mucormycosis Graph 4: Age wise and Sex wise Distribution of Mucormycosis Site Males Females Cerebral 2 - Gender Distribution Occular 6 - In the present study out of 116 positive cases, males were Paranasal sinuses 87 21 95 were males and 21 were females. Total 95 21 Graph 5: Gender distribution in Mucormycosis cases Graph 3: Site wise and sex wise distribution Table 2: Age and Sex wise Distribution of Mucormycosis
Load more

Recommended publications
  • An Open-Label Parallel-Arm Phase II Multicentre Randomized Controlled Trial (PLACID Trial)
    medRxiv preprint doi: https://doi.org/10.1101/2020.09.03.20187252; this version posted September 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Title Page Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial) Anup Agarwal, Aparna Mukherjee, Gunjan Kumar, Pranab Chatterjee, Tarun Bhatnagar, Pankaj Malhotra and PLACID Trial Collaborators The names and affiliations of PLACID Trial Collaborators are provided in Annexure 1 Running title: Convalescent plasma in COVID-19 Corresponding Author: Name: Dr. Aparna Mukherjee MD, PhD Affiliation: Scientist-E, Clinical Trial and Health Systems Research Unit, Indian Council of Medical Research Full Address: Indian Council of Medical Research V. Ramalingaswamy Bhawan PO Box No. 4911 Ansari Nagar, New Delhi – 110029, India Email: [email protected] [email protected] 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.09.03.20187252; this version posted September 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Name Highest Affiliation Full Address Degree Anup Agarwal MBBS Consultant, Indian Council of Clinical Trial & Health Systems Research Unit, Medical Research.
    [Show full text]
  • Aurora Residency Programs Sinai Samaritan Medical Center House Staff Roster, 1999-2000
    Advocate Aurora Health Advocate Aurora Health Institutional Repository Aurora Sinai Medical Center Books, Documents, and Pamphlets Aurora Sinai Medical Center June 2016 Aurora Residency Programs Sinai Samaritan Medical Center House Staff Roster, 1999-2000 Aurora Health Care Follow this and additional works at: https://institutionalrepository.aah.org/asmc_books This Document is brought to you for free and open access by the Aurora Sinai Medical Center at Advocate Aurora Health Institutional Repository. It has been accepted for inclusion in Aurora Sinai Medical Center Books, Documents, and Pamphlets by an authorized administrator of Advocate Aurora Health Institutional Repository. For more information, please contact [email protected]. AURORA RESIDENCY PROGRAMS Sinai Samaritan Medical Center c AuroraHealthCare® House Staff Roster G. A. Prasad, MD Michael Belete, MD Sharon Doss, MD July 1999 - June 2000 Internal Medicine IV Internal Medicine III Internal Medicine III All India Institute of University of St. John’s Medical College Medical Sciences WisconsinlMadison Kim Erdmann, MD Nalini Guda, MD Shanthi Joseph, MD Pawan Juneja, MD Syed Mohiuddin, MD Internal Medicine III Internal Medicine III Internal Medicine III Internal Medicine III Internal Medicine III Medical College of Wisconsin Kurnool Medical College St. John’s Medical College Rohtek Medical College Siddhartha Medical College Kirk Nelson, MD Mouhammed Rihawi, MD Aileen Tan, MD Sucharita Varikuti, MD Catherine Yoo, MD Internal Medicine III Internal Medicine III Internal Medicine III Internal Medicine III Internal Medicine III University of Illinois-Rockford University of Damascus Far Eastern University S.C.B. Medical College St. George’s University School of Medicine 1 Syed Zaidi, MD Olivera Zubic, MD Deepak Chikkala, MD Yoganandan Gundamaraj, MD Rozina S.
    [Show full text]
  • 1 MINUTES August 5, 2020 STATE of NEW HAMPSHIRE BOARD of MEDICINE the Regularly Scheduled Meeting of the New Hampshire Board Of
    MINUTES August 5, 2020 STATE OF NEW HAMPSHIRE BOARD OF MEDICINE The regularly scheduled meeting of the New Hampshire Board of Medicine was held electronically via Zoom on the above date, beginning at 8:00 A.M. Unless otherwise indicated, the members present and participating were: Daniel P. Potenza, M.D., President; David C. Conway, M.D., Vice President; Emily R. Baker, M.D.; Michael Barr, M.D.; Jonathan Ballard, MD, MPH, DHHS Medical Director; Gilbert J. Fanciullo, M.D.; Nina C. Gardner, Public Member; Donald L. LeBrun, Public Member and Linda Tatarczuch, Public Member. Absent were: John H. Wheeler, D.O. and Susan M. Finerty, P.A. Dr. Potenza, Board President, opened the meeting at 8:05 A.M. (See attached Script read prior to the start of the meeting). Motion to commence 1st non-public session: On motion of Dr. Conway, seconded by Dr. Fanciullo, at 8:05 A.M., the Board voted to conduct a non-public session for the purpose of discussing investigations of alleged licensee misconduct, physician applications with irregularities and other confidential Board business and noting that such a non-public session is authorized by RSA 91-A:3, II (c), RSA 91-A:3, II (e), RSA 91-A:5, IV, RSA 329:18, I, RSA 329:18-a, IV, RSA 329:29, Lodge v. Knowlton, 119 N.H. 574 (1978), and the Board's executive and deliberative privileges. Each member recorded his or her vote on the motion, which passed by the unanimous poll vote of all members present. Dr. Potenza Yes Dr.
    [Show full text]
  • SRI VENKATESWARA INSTITUTE of MEDICAL SCIENCES, TIRUPATI (A University Established by an Act No
    SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, TIRUPATI (A University established by an act No. 12/95 ofA.P. State Legislature) TIRUMALA TIRUPATI DEVASTHANAMS Admissions 2014 MCh Urology revised provisional merit list 1. The candidates are informed to verify the particulars notified in the following revised provisional merit list including trie area belongs to, number of attempts in PG degree. The genuine objections (if any) may be informed with documentary evidence by email ([email protected]} on or before 19.07.2014. 2. Area belongs is decided based on the guidelines prescribed in the AP presidential order-1974 (G.O.P No. 646, dt: 10.07.1979) Explanation: a. The candidate who studied both MBBS and PG degree in a college in a particular area within the state of Andhra Pradesh/Telangana shall be considered in that particular area only. b. The candidate who studied MBBS in a college located in AU area and PG degree in a college located in OU area, his/her area shall be considered under AU area, because out of the maximum 7 years of study preceding the qualifying examination, the maximum period of the study is in AU area. c. The candidate who studied MBBS in a college located outside the state of Andhra Pradesh/Telangana and PG degree in a college located in OU area, his/her area shall be considered under Un-Reserved category, since, the maximum 7 years of study including the qualifying examination is not from within the state. d. The candidate who studied MBBS in a college located in AU area and PG degree in a college located in outside the state of Andhra Pradesh/Telangana, his/her area shall be considered under Un-reserved, since, the qualifying examination is studied from outside the state of Andhra Pradesh e.
    [Show full text]
  • BR (CA) 5 - REVISED Recommendation
    THE STATE EDUCATION DEPARTMENT / THE UNIVERSITY OF THE STATE OF NEW YORK / ALBANY, NY 12234 TO: The Honorable the Members of the Board of Regents FROM: Douglas E. Lentivech SUBJECT: Report of the Committee on the Professions Regarding Licensing Petitions DATE: October 24, 2019 AUTHORIZATION(S): SUMMARY Issue for Consent Agenda Should the Regents approve the recommendations of the Committee on the Professions pertaining to licensing petitions as listed on the attachment? Reason(s) for Consideration Required by State Statute. Proposed Handling This question will come before the full board at its November 5, 2019 meeting where it will be voted on and action taken. Procedural History Section 6506(5) of the Education Law and Section 24.7 of the Rules of the Board of Regents authorize the Regents to waive education, experience and examination requirements for a professional license as well as to confer the degree Doctor of Medicine. Background Information There are 14 requests for the conferral of the degree Doctor of Medicine for review and determination. BR (CA) 5 - REVISED Recommendation It is recommended that the Regents approve the recommendations of the Committee on the Professions regarding the degree conferrals. Timetable for Implementation Approval of the Committee on the Professions’ recommendations will be effective, November 5, 2019. 2 Cases Presented to Board of Regents on November 5, 2019 SUMMARY REPORT EDUCATION EXAMINATION PROFESSION Experience Confer Degree Three-Year Pre- Post- Doctor of Limited Professional Professional Graduate Proficiency Licensing Medicine License Medicine 19-135-60C To 19-148-60C OTHER: Total for fiscal year to date: 140 Total for calendar year to date: 196 Board of Regents: November 5, 2019 MEDICINE Petition for: Conferral of the degree Doctor of Medicine (M.D.) pursuant to Section 6529 of the Education Law.
    [Show full text]
  • University Student Catalog/Handbook Academic Year 2018-2019 (7/1/2018 – 6/30/2019)
    University Student Catalog/Handbook Academic Year 2018-2019 (7/1/2018 – 6/30/2019) Revision 1.1.1 ABOUT THIS STUDENT CATALOG/HANDBOOK California University of Science and Medicine (CUSM) has established CUSM School of Medicine (known as “CalMed”), which is projected to be the eleventh allopathic medical school in the state of California once it has received appropriate authority and accreditation status. Prospective students will be primarily drawn from a national pool of applicants with a focus on disadvantaged* California and Inland Empire applicants. CUSM students are expected to be familiar with the information in the Student Catalog/Handbook and other publications relating to student conduct and attendance. Prospective students may use this document as a reference for CUSM information, policies, and procedures. Since this Student Catalog/Handbook is prepared in advance of the period of time that covers, changes in programs and regulations may occur. All policies are subject to revision as necessary. Any changes or additions to this Student Catalog/Handbook will be made in writing and will be provided to all students in print or electronically. These policies are specific to the CUSM educational programs and related services. CUSM will publish all current policies and procedures affecting students on the CUSM website (www.calmedu.org). The ‘catalog,’ in the context below, includes both the University Catalog and the program-specific Student Handbook sections, i.e., the set of the CUSM Student Catalog/Handbook. As a prospective student, you are encouraged to review this catalog prior to signing an enrollment agreement. You are also encouraged to review the School Performance Fact Sheet, which must be provided to you prior to signing an enrollment agreement.
    [Show full text]
  • Research in Indian Medical Institutes
    90 THE NATIONAL MEDICAL JOURNAL OF INDIA VOL. 4, NO.2 Research in Indian medical institutes K. SUDHAKAR REDDY, P. SAHNI, G. K. PANDE, S. NUNDY ABSTRACT We compared these results with the output of ten other Background and methods. The research output of medical well known medical institutions elsewhere. institutions in India is thought to vary considerably, although no studies have been done since 1965. We consulted the RESULTS Corporate Index of the Science Citation Index to count the number of publications included from each of the 128 Research output between 1980 and 1988 (Table I) medical institutions in India between 1981 and 1988. We also Of the 128 Indian medical colleges existing in 1988, 121 compared these results to the number of publications from lead- were listed in the Corporate Index during 1980 to 1988. ing international institutions in 1988. Only 6 (4.7%) published more than 50 articles a year in Results. Only 6 (4.7%) institutions had over 50 articles per SCI covered journals. These were the All India Institute year included, 33 (26%) had 5 to 50 articles included, 43 (38%) of Medical Sciences, New Delhi; the Postgraduate Institute had 1 to 5 articles and 41 (32%) had less than one article of Medical Education and Research, Chandigarh; the included. Seven medical colleges had none. Only the All Institute of Medical Sciences in Varanasi; the Tata India Institute of Medical Sciences, New Delhi and the Post- graduate Institute of Medical Education and Research, Memorial Hospital and Cancer Research Institute in Chandigarh could be compared with the world leaders.
    [Show full text]
  • PHYSICIAN DIRECTORY 2017 Find the Doctor Who’S Right for You at TMC, We Are Proud to Be a MISSION STATEMENT Top-Performing Healthcare Provider
    PHYSICIAN DIRECTORY 2017 find the doctor who’s right for you At TMC, we are proud to be a MISSION STATEMENT top-performing healthcare provider. Providing care. quality Texoma Medical Center has been dedicated to providing quality care, delivering innovative services, and exceeding expectations for over a half-century. At TMC, Delivering services. we make it a priority to seek out opportunities to add new programs, services innovative and technology to meet the changing healthcare needs of our patients. Over the Exceeding . years, we’ve grown from a community hospital into a family of healthcare providers expectations delivering a broad range of advanced medical services for the people of Texoma. Our commitment to quality is demonstrated by the numerous awards and national accreditations that we have received in areas such as Chest Pain, Trauma, Stroke, Breast Care and Bariatrics. Most recently, TMC was named “Best Hospital” by the readers of the Herald Democrat for the tenth time. Please use this directory as a guide to our ever-growing medical staff. You can always call Direct Doctors Plus®, our free physician referral service, at 903.416.DOCS (3627) to find the right doctor for you. For more information on TMC, visit our website at www.texomamedicalcenter.net. All of the physicians and staff at Texoma Medical Center look forward to helping to keep you and your family healthy. We are dedicated to quality healthcare in North Texas and Southern Oklahoma. Ronald T. Seal CEO/Managing Director Texoma Medical Center TABLE OF CONTENTS Your health Allergy/Immunology ................................................................................. 6 Anesthesiology ......................................................................................... 7 Texoma Medical Center offers major specialty services from open-heart surgery to Breast Surgery ..........................................................................................
    [Show full text]
  • Study of Correlation Between Bmi and Pefr Rate in Rayalaseema Population G
    International Journal of Integrative Medical Sciences, Int J Intg Med Sci 2019, Vol 6(2):780-84. ISSN 2394 - 4137 DOI: https://dx.doi.org/10.16965/ijims.2019.106 Original Research Article STUDY OF CORRELATION BETWEEN BMI AND PEFR RATE IN RAYALASEEMA POPULATION G. Reen Prasoona, S Sarah Nightigale *. Assistant Professor, Physiology Kurnool Medical college, Kurnool, Rayalaseema, Andhra Pradesh, India. ABSTRACT Introduction: Obesity, waist-hip ratio, rather than Body Mass Index (BMI) explains large part of the variance in pulmonary gas exchange. Hence, present study will be taken up to study the correlation between BMR, and Peak Expiratory flow rate (PEFR) in healthy underweight, normal weight, and obese adults. Materials and Methods: The present cross section study conducted in the department of Physiology, Kurnool medical college, Kurnool, with randomly selected 100 health voluntaries from both the sexes of the age group 20-40 yrs. The height and weight were taken to calculated BMI and PEFR was recorded. Results: The mean PEFR values were significantly lower in obese group when compared to normal weight. BMI was significantly and negatively correlated with PEFR in both males and females. Conclusion: The isolated effects of obesity unassociated with other diseases must be identified and the analysis of those effects should be stratified so that obesity related dysfunction may be evaluated in detail. KEY WORDS: Body Mass Index, Obesity, and, Peak Expiratory Flow Rate. Address for correspondence: S Sarah Nightigale, Assistant Professor, Physiology Kurnool Medical college, Kurnool, Rayalaseema, Andhra Pradesh, India. E-Mail: [email protected] Online Access and Article Informtaion Quick Response code International Journal of Integrative Medical Sciences ISSN (P): 2394 - 6318.
    [Show full text]
  • Dr. Sai Sampath Kumar Natuva D.N.B (Paed), D.M (Neuro),FRCP (Glasg), FIMSA
    Dr. Sai Sampath Kumar Natuva D.N.B (Paed), D.M (Neuro),FRCP (Glasg), FIMSA. Fellow of the European Academy of Neurology - FEAN Professor & Head, Department of Neurology, Narayana Medical College, Nellore, A.P., India. ADDRESS Work address: Home address: Dr.N.S .Sampath Kumar, Dr.N.S .Sampath Kumar, Professor & Head, Department of Neurology S/o N. Subramanyam, Narayana Medical College, 87/1388-3-1, Nandikotkur Road, Chinthareddypalem, Nellore-524003, A.P., India Jayaram nagar, Mob: 9849959527 Kunool-518002, A.P., India Office: 0861 2317963 Email:[email protected] Email:[email protected] PERSONAL INFORMATION Phone: +919849959527 Phone:DOB: +919849959527 02/08/1973; Male, Married ACADEMIC QUALIFICATION Duration Course Awarding Institute 2003-2006 Doctor of Medicine in Sri Venkateswara Institute of Neurology Medical Sciences 2000-2002 DNB in Pediatrics Madras Medical College 1998-2000 DCH Kurnool Medical College 1990-1996 MBBS Kurnool Medical College 1988-1990 Intermediate in Bi.P.C Board of Intermediate, Andhra Pradesh 1987-1988 Matriculation Board of High School Education, Andhra Pradesh Professional Experience 10/2017-Till date Professor & HOD in the Department of Neurology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, INDIA. 6/2013-9/2017 Professor in the Department of Neurology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, INDIA. 9/2009-5/2013 Consultant Neurologist & DNB Neurology faculty & Guide, Yashoda Hospital, Hyderabad 7/2008-8/2009 Assistant Professor in the Department of Neurology, SV Medical College, Tirupati 3/2007-6/2008 Assistant Professor in the Department of Neurology, Narayana Medical College, Nellore 12/2006-2/2007 Assistant Professor in the Department of Neurology, SVIMS ,Tirupathi ❖ Reviewer for prominent international journals like BMJ.
    [Show full text]
  • Nathan Douglass, M.D. Specializes in Orthopedic Hand & Upper Limb
    Anate Aelion Brauer, M.D. specializes in Reproductive Endocrinology & Infertility. She received her medical degree from the George Washington University School of Medicine. She then went on to complete her Obstetrics & Gynecology residency at NY Presbyterian Hospital, followed by her Repro- ductive Endocrinology and Infertility fellowship. Dr. Brauer is board certified in both Obstetrics & Gynecology and Reproductive Endocrinology & Infertili- ty. Office: Shady Grove Fertility New York Medical Professionals Phone: 212-324-2229 Allan Brook, M.D. specializes in Neuro-Teleradiology. He received his medical degree from Tel Aviv University in Israel. He completed his intern- ship at NYU Langone Medical Center. He then went of to complete his Diag- nostic Radiology residency at Stony Brook University, where he remained for his Neuroradiology fellowship. Dr. Brook is board certified in Diagnostic Radi- ology & Neuroradiology. Office: Montefiore Medical Center Phone: 718-920-4321 Nathan Douglass, M.D. specializes in Orthopedic Hand & Upper Limb Surgery. He received his medical degree from College of Physicians & Sur- geons at Columbia University. He then went on to complete his Orthopedic Surgery residency at Stanford University, where he remained for his Hand & Upper Limb fellowship. Dr. Douglass is board certified in Orthopedic Surgery. Office: White Plains Hospital Physician Associates Phone: 914-337-3976 Mazen Fouany, M.D. specializes in Obstetrics & Gynecology. He re- ceived his medical degree from University of Balamand in Beirut, Lebanon. He then went on to complete his General Surgery internship at St. Georges University Hospital, where he remained for his Obstetrics & Gynecology resi- dency. Dr. Fouany is board certified in Obstetrics & Gynecology. Office: White Plains Hospital Physician Associates Phone: 914-285-0530 Harish Guddati, M.B.B.S.
    [Show full text]
  • 1985 Kurnool Medical College, Kurnool
    Dr M. V. Ramanamma , M.D.,. ​ Rector N.T.R. University of Health Sciences, Vijayawada , Andhra Pradesh . ​ Date of Birth:February 17, 1953 ​ EDUCATION: ​ Degree Year Of Passing University Andhra Medical College , MBBS 1975 Visakhapatnam Kurnool Medical College, MD(Microbiology) 1985 Kurnool PUBLICATIONS: (in research) 1. Grouping pattern of Streptococcal isolates in Rayalaseema region - The Indian Practitioner, Oct 1992, Vol .XLV No 10 . 2. A preliminary report on the sero prevalence of HIV - 2 in Visakhapatnam- Indian Journal of Medical Microbiology . 3. A study of HIV seropositivity among pregnant women at Visakhapatnam, Indian Journal of Obstetrics and Gynaecology, April 1997 . 4. Incidence of Hepatitis B infection among HIV seropositive patients in Visakhapatnam, Indian Journal of Medical Microbiology 2008 18(4). MEMBERSHIP: 1. Member, AIDS Society of India 2. Member, Indian Association of Medical Microbiologists 3. Member, Indian Medical Association PROFESSIONAL EXPERIENCE: Designation Institution Duration Rector Dr. NTR University of Health Sciences, A.P. From 2011, July Professor and H.O.D Rajiv Gandhi Institute of Medical Sciencesr,Srikakulam 18-5-2011 to 16-8-2011 Director of Medical Government of Andhra Pradesh 07-02-2010 to 28-02-2011 Education(Academic) Principal Govt. Siddhartha Medical College, Vijayawada 25-06-2008 to 06-02-2010 Professor and HOD Kakatiya Medical College 01-01-1996 to 24-06-2008 Kurnool Medical College, Kurnool Andhra Medical 03-02-1985 to 24-10-1989 Assistant Professor College, Visakhaptnam to 31-12-1995 Tutor Kurnool Medical College, Kurnool 06-02-1982 to 02-02-1985 Medical Officer Primary Health Center, Gonegandla, Kurnool 03-07-1978 to 26-11-1981 ACADEMIC ACTIVITY: 1.
    [Show full text]